No Data
No Data
Enanta Pharmaceuticals (ENTA) Soars 6.7%: Is Further Upside Left in the Stock?
Does Enanta Pharmaceuticals (NASDAQ:ENTA) Have A Healthy Balance Sheet?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you
Enanta Pharmaceuticals(ENTA.US) Officer Sells US$89,589.78 in Common Stock
$Enanta Pharmaceuticals(ENTA.US)$ Officer Kieffer Tara Lynn sold 7,266 shares of common stock on Jun 17, 2024 at an average price of $12.33 for a total value of $89,589.78.Source: Announcement What is
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
PDF Version WATERTOWN, Mass.--(BUSINESS WIRE)--May 29, 2024-- Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virolog
Express News | Enanta Pharmaceuticals Inc : Evercore ISI Cuts Target Price to $30 From $35
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) shareholders are probably feeling a little disappointed, since its shares fell 8.3% to US$12.76 in the week after its latest quarterly results. Revenue
No Data